Global Virtual Clinical Trials Market Industry Analysis and Forecast Report Released
Reportlinker.com has announced the release of the report "Global Virtual Clinical Trials Market By Study Type, By Indication, By Region, Industry Analysis and Forecast, 2020 – 2026."
The market is significantly driven by growth in R&D activities, the growing digitization in healthcare, and the adoption of telehealth. Virtual Clinical Trials or remote/decentralized trails are a relatively new but still underused technique of carrying out clinical research taking complete benefit of technologies like apps, online social interaction platforms, and electronic monitoring tools. Advances in technology, collaborations between clinical research companies, biotechnology companies, and pharmaceutical and support initiatives from governments, are expected to boost the market. The market’s size is expected to reach $10 billion by 2026, rising at a market growth of 6. 5% CAGR during the forecast period.
For more of report’s analysis, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FSP Outsourcing in Clinical Research: Trends and Opportunities
June 9th 2025When drug developers choose the right outsourcing strategies in clinical research, they can gain significant benefits in terms of quality, efficiency, and operational success. In its third annual Functional Service Provider (FSP) Trends Report, Thermo Fisher Scientific’s clinical research business—PPD—gathered insights from 150 global biotech and pharma leaders to determine how FSP models help sponsors address common industry obstacles.
